Skip to main content
. 2017 Aug 4;20(2):131–137. doi: 10.4103/aja.aja_28_17

Figure 5.

Figure 5

Changes in on-treatment circulating serum sex steroids from baseline to 6 months in the testosterone group of the TOM Trial according to cardiovascular event occurrence (adapted from Basaria et al.44). TOM: Testosterone in Older Men with Mobility Limitation; CVD: cardiovascular disease.